Pharmacokinetics of a multipurpose pod-intravaginal ring simultaneously delivering five drugs in an ovine model

John A. Moss; Amanda M. Malone; Thomas J. Smith; Sean Kennedy; Cali Nguyen; Kathleen L. Vincent; Massoud Motamedi; Marc M. Baum

doi:10.1128/AAC.00547-13

Pharmacokinetics of a multipurpose pod-intravaginal ring simultaneously delivering five drugs in an ovine model

John A. Moss, Amanda M. Malone, Thomas J. Smith, Sean Kennedy, Cali Nguyen, Kathleen L. Vincent, Massoud Motamedi, Marc M. Baum

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Abstract

Multipurpose technologies that simultaneously protect from sexually transmitted infections and unintended pregnancy are urgently needed. Pod-intravaginal rings (IVRs) formulated with the antiretroviral agents (ARVs) tenofovir, nevirapine, and saquinavir and the contraceptives etonogestrel and estradiol were evaluated in sheep. Steady-state concentrations were maintained for 28 days with controlled, sustained delivery. This proof-of-principle study demonstrates that pod IVRs can deliver three ARVs from different mechanistic classes and a progestin-estrogen combination over the wide range needed for putative preventative efficacy.

Original language	English (US)
Pages (from-to)	3994-3997
Number of pages	4
Journal	Antimicrobial agents and chemotherapy
Volume	57
Issue number	8
DOIs	https://doi.org/10.1128/AAC.00547-13
State	Published - Aug 2013

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)
Infectious Diseases

Access to Document

10.1128/AAC.00547-13

Cite this

@article{b4c7157793be49d783d5654eca9c6296,

title = "Pharmacokinetics of a multipurpose pod-intravaginal ring simultaneously delivering five drugs in an ovine model",

abstract = "Multipurpose technologies that simultaneously protect from sexually transmitted infections and unintended pregnancy are urgently needed. Pod-intravaginal rings (IVRs) formulated with the antiretroviral agents (ARVs) tenofovir, nevirapine, and saquinavir and the contraceptives etonogestrel and estradiol were evaluated in sheep. Steady-state concentrations were maintained for 28 days with controlled, sustained delivery. This proof-of-principle study demonstrates that pod IVRs can deliver three ARVs from different mechanistic classes and a progestin-estrogen combination over the wide range needed for putative preventative efficacy.",

author = "Moss, {John A.} and Malone, {Amanda M.} and Smith, {Thomas J.} and Sean Kennedy and Cali Nguyen and Vincent, {Kathleen L.} and Massoud Motamedi and Baum, {Marc M.}",

year = "2013",

month = aug,

doi = "10.1128/AAC.00547-13",

language = "English (US)",

volume = "57",

pages = "3994--3997",

journal = "Antimicrobial agents and chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "8",

}

TY - JOUR

T1 - Pharmacokinetics of a multipurpose pod-intravaginal ring simultaneously delivering five drugs in an ovine model

AU - Moss, John A.

AU - Malone, Amanda M.

AU - Smith, Thomas J.

AU - Kennedy, Sean

AU - Nguyen, Cali

AU - Vincent, Kathleen L.

AU - Motamedi, Massoud

AU - Baum, Marc M.

PY - 2013/8

Y1 - 2013/8

N2 - Multipurpose technologies that simultaneously protect from sexually transmitted infections and unintended pregnancy are urgently needed. Pod-intravaginal rings (IVRs) formulated with the antiretroviral agents (ARVs) tenofovir, nevirapine, and saquinavir and the contraceptives etonogestrel and estradiol were evaluated in sheep. Steady-state concentrations were maintained for 28 days with controlled, sustained delivery. This proof-of-principle study demonstrates that pod IVRs can deliver three ARVs from different mechanistic classes and a progestin-estrogen combination over the wide range needed for putative preventative efficacy.

AB - Multipurpose technologies that simultaneously protect from sexually transmitted infections and unintended pregnancy are urgently needed. Pod-intravaginal rings (IVRs) formulated with the antiretroviral agents (ARVs) tenofovir, nevirapine, and saquinavir and the contraceptives etonogestrel and estradiol were evaluated in sheep. Steady-state concentrations were maintained for 28 days with controlled, sustained delivery. This proof-of-principle study demonstrates that pod IVRs can deliver three ARVs from different mechanistic classes and a progestin-estrogen combination over the wide range needed for putative preventative efficacy.

UR - http://www.scopus.com/inward/record.url?scp=84880304261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880304261&partnerID=8YFLogxK

U2 - 10.1128/AAC.00547-13

DO - 10.1128/AAC.00547-13

M3 - Article

C2 - 23752507

AN - SCOPUS:84880304261

SN - 0066-4804

VL - 57

SP - 3994

EP - 3997

JO - Antimicrobial agents and chemotherapy

JF - Antimicrobial agents and chemotherapy

IS - 8

ER -

Pharmacokinetics of a multipurpose pod-intravaginal ring simultaneously delivering five drugs in an ovine model

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this